Professional Documents
Culture Documents
(COVID-19)
Situation Report – 193
Data as received by WHO from national authorities by 10:00 CEST, 31 July 2020
Highlights
In his regular media briefing, WHO Director-General Dr Tedros highlighted the high rates of COVID-19 in long-
term care facilities, drawing attention to a recently published WHO policy brief. Dr Tedros also reminded us
that COVID-19 is not only a disease that affects the elderly and that “young people must take the same
precautions to protect themselves and protect others as everyone else. They can be leaders – they should be
leaders and drivers of change.”
During this pandemic, even the strongest health systems in the world have been overwhelmed and unable to
adequately provide essential health services and care for conditions not associated with COVID-19. In an
address to the Virtual Symposium on the Impact of the COVID-19 Pandemic and HIV on SDG 3.3, WHO Regional
Director for Europe, Dr Hans Henri P. Kluge emphasized the need to “be on the alert to expand capacity to
deal with a resurgence of COVID-19 and, at the same time, to maintain essential health services.”
WHO has published interim guidance on the provision of safe water, sanitation and waste management and
hygienic conditions which is essential for preventing disease and for protecting human health during all
infectious disease outbreaks, including during the COVID-19 pandemic.
Today’s Subject in Focus highlights new guidance on public health considerations while resuming international
travel.
Globally 17 106 007 cases (292 527) 668 910 deaths (6 812)
Africa 770 421 cases (16 031) 13 234 deaths (396)
Americas 9 152 173 cases (171 946) 351 121 deaths (4 567)
Eastern Mediterranean 1 533 357 cases (12 612) 39 661 deaths (458)
Europe 3 333 300 cases (25 241) 212 520 deaths (438)
South-East Asia 2 009 963 cases (60 113) 44 031 deaths (914)
Western Pacific 306 052 cases (6 584) 8 330 deaths (39)
Subject in Focus: Public health considerations while resuming international
travel
In response to the COVID-19 pandemic,198 countries/areas/territories have implemented measures that
are significantly interfering with international traffic as defined under Article 43 of the International
Health Regulations (IHR 2005). Only one third of the 198 countries have provided a public health
rationale for these measures, and only a few countries conduct and communicate regular risk
assessments and reviews of measures. As of 23 July 2020, only 63 of 198 countries/areas/territories
have lifted measures that were implemented to restrict the international movement of people.
As countries consider to either gradually lift or re-introduce restrictions with the intention of controlling
virus transmission, WHO published “Public health considerations while resuming international travel” in
order to inform national decision-making processes. The publication advises countries to conduct risk
assessments, as not doing so while restricting travel may have adverse effects on the overall public
health situation.
The multi-sectoral risk assessment should take into account country context, the local epidemiology and
transmission patterns, the national health and social measures to control the outbreak, and the
capacities of health systems in both departure and destination countries, including at points of entry.
Measures must be proportionate to the public health risks and should be regularly reassessed and
communicated to the public.
The guidance underlines the importance of basic surveillance, isolation of cases, contact tracing and self-
monitoring as well as risk communication and community engagement. Support for countries in defining
their needs and priorities is also provided in the form of an overview of capacities at points of entry
along with considerations for the use of digital tools and immunity certificates.
Surveillance
Figure 1. Number of confirmed* COVID-19 cases reported in the last seven days by country, territory or area, 25 July to 31 July **
Case definitions
WHO periodically updates the Global Surveillance for human infection with coronavirus disease (COVID-19)
document which includes surveillance definitions.
A COVID-19 death is defined for surveillance purposes as a death resulting from a clinically compatible illness
in a probable or confirmed COVID-19 case, unless there is a clear alternative cause of death that cannot be
related to COVID-19 disease (e.g. trauma). There should be no period of complete recovery between the
illness and death.
Further guidance for certification and classification (coding) of COVID-19 as cause of death is available here
and here.
Annex 1: Data, table and figure notes
Caution must be taken when interpreting all data presented. Differences are to be expected between
information products published by WHO, national public health authorities, and other sources using different
inclusion criteria and different data cut-off times. While steps are taken to ensure accuracy and reliability, all
data are subject to continuous verification and change. Case detection, definitions, testing strategies,
reporting practice, and lag times differ between countries/territories/areas. These factors, amongst others,
influence the counts presented, with variable underestimation of true case and death counts, and variable
delays to reflecting these data at global level.
The designations employed, and the presentation of these materials do not imply the expression of any
opinion whatsoever on the part of WHO concerning the legal status of any country, territory or area or
of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines
on maps represent approximate border lines for which there may not yet be full agreement. Countries,
territories and areas are arranged under the administering WHO region.
The mention of specific companies or of certain manufacturers’ products does not imply that they are
endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned.
Errors and omissions excepted, the names of proprietary products are distinguished by initial capital
letters.
[1] All references to Kosovo should be understood to be in the context of the United Nations Security Council
resolution 1244 (1999). In the map, number of cases of Serbia and Kosovo (UNSCR 1244, 1999) have been
aggregated for visualization purposes.
Due to the recent trend of countries conducting data reconciliation exercises which remove large numbers of
cases or deaths from their total counts, WHO will now display such data as negative numbers in the “new
cases” / “new deaths” columns as appropriate. This will aid readers in identifying when such adjustments
occur. When additional details become available that allow the subtractions to be suitably apportioned to
previous days, graphics will be updated accordingly. Prior situation reports will not be edited; see
covid19.who.int for the most up-to-date data.
Additional table notes
ii “Territories” include territories, areas, overseas dependencies and other jurisdictions of similar status.
• Update 31 July 2020, Ireland: Counts adjusted retrospectively by national authorities: case and death
counts adjusted for 1–19 March, 25 May, 31 May, 26–30 July.
• Update 31 July 2020, Belgium: Counts adjusted retrospectively by national authorities: case and death
counts adjusted for 18–30 July.
• Update 31 July 2020, Guadeloupe: Counts adjusted retrospectively by national authorities: case counts
adjusted on 30 July.
• Update 31 July 2020, Saint Barthélemy: Counts adjusted retrospectively by national authorities: case
counts adjusted on 30 July.
• Update 31 July 2020, Saint Martin: Counts adjusted retrospectively by national authorities: case counts
adjusted on 30 July.